KRT19 and hepatocellular carcinoma: Patients with CK19-positive (CK19+) HCC demonstrate poorer prognosis, reduced overall survival (OS) and recurrence-free survival (RFS), and higher recurrence rates, compared with CK19-negative (CK19-) HCC patients (3, 4).